OARO Signs Contract with GlaxoSmithKline
OARO is pleased to announce that it has signed a SaaS contract to deploy its OARO COMPLY solution at GlaxoSmithKline's (GSK) production site in Aranda de Duero, Spain. OARO COMPLY is a document management system with the capacity to track a company's specific workflow with immutable audit-trails, verifiable electronic documents and sophisticated proof of process while maintaining a high level of data integrity.
OARO COMPLY electronically tracks all steps in the quality control process and will allow GSK to instantly retrieve data that can be used in the audit process, to assess quality control factors and to analyze and improve process standards. OARO COMPLY is designed to replace paper-based tracking systems, reducing manual tracking activities, paper documents and greatly increasing data integrity.
Joel Leetzow, OARO CEO stated, "This next step in our on-going relationship with GSK is a true indication of the value OARO can deliver. GSK represents the gold standard in the life science industry, we are proud to be selected by such an outstanding partner."
Read the full press release here